Published in Invest Ophthalmol Vis Sci on November 01, 2016
Accurate normalization of real-time quantitative RT-PCR data by geometric averaging of multiple internal control genes. Genome Biol (2002) 82.19
Fiji: an open-source platform for biological-image analysis. Nat Methods (2012) 56.92
The number of people with glaucoma worldwide in 2010 and 2020. Br J Ophthalmol (2006) 25.47
qBase relative quantification framework and software for management and automated analysis of real-time quantitative PCR data. Genome Biol (2007) 16.15
Matrix metalloproteinases and the regulation of tissue remodelling. Nat Rev Mol Cell Biol (2007) 10.17
MMP-9/gelatinase B is a key regulator of growth plate angiogenesis and apoptosis of hypertrophic chondrocytes. Cell (1998) 9.70
Glaucoma. Lancet (2011) 4.29
Metalloproteinase inhibitors: biological actions and therapeutic opportunities. J Cell Sci (2002) 4.23
Biochemistry and molecular biology of gelatinase B or matrix metalloproteinase-9 (MMP-9). Crit Rev Biochem Mol Biol (2002) 3.53
Tissue inhibitors of metalloproteinases in cell signaling: metalloproteinase-independent biological activities. Sci Signal (2008) 2.97
Inherited glaucoma in DBA/2J mice: pertinent disease features for studying the neurodegeneration. Vis Neurosci (2005) 2.86
Effect of matrix metalloproteinases activity on outflow in perfused human organ culture. Invest Ophthalmol Vis Sci (1998) 2.43
Matrix metalloproteinases and their multiple roles in neurodegenerative diseases. Lancet Neurol (2009) 2.35
Brn3a as a marker of retinal ganglion cells: qualitative and quantitative time course studies in naive and optic nerve-injured retinas. Invest Ophthalmol Vis Sci (2009) 2.17
Matrix metalloproteinases in brain development and remodeling: synaptic functions and targets. J Neurosci Res (2007) 2.13
Structural changes of the trabecular meshwork in different kinds of glaucoma. Exp Eye Res (2008) 2.05
Retinal ganglion cell apoptosis in glaucoma is related to intraocular pressure and IOP-induced effects on extracellular matrix. Invest Ophthalmol Vis Sci (2005) 2.02
A biomechanical paradigm for axonal insult within the optic nerve head in aging and glaucoma. Exp Eye Res (2010) 1.85
Changes in aqueous humor dynamics with age and glaucoma. Prog Retin Eye Res (2005) 1.82
Understanding mechanisms of pressure-induced optic nerve damage. Prog Retin Eye Res (2005) 1.79
Effects of mechanical stretching on trabecular matrix metalloproteinases. Invest Ophthalmol Vis Sci (2001) 1.60
Matricellular proteins as modulators of wound healing and the foreign body response. Thromb Haemost (2003) 1.52
Transgenic mice expressing the Tyr437His mutant of human myocilin protein develop glaucoma. Invest Ophthalmol Vis Sci (2008) 1.44
Ultrahistochemical studies on tangential sections of the trabecular meshwork in normal and glaucomatous eyes. Invest Ophthalmol Vis Sci (1981) 1.37
Expression of mutated mouse myocilin induces open-angle glaucoma in transgenic mice. J Neurosci (2006) 1.32
Patterns of intraocular pressure elevation after aqueous humor outflow obstruction in rats. Invest Ophthalmol Vis Sci (2000) 1.28
A semiautomated targeted sampling method to assess optic nerve axonal loss in a rat model of glaucoma. Nat Protoc (2010) 1.27
Signaling pathways used in trabecular matrix metalloproteinase response to mechanical stretch. Invest Ophthalmol Vis Sci (2003) 1.27
Glycosaminoglycans of the human trabecular meshwork in primary open-angle glaucoma. Invest Ophthalmol Vis Sci (1996) 1.26
Ultrastructure of the trabecular meshwork in untreated cases of primary open-angle glaucoma (POAG). Exp Eye Res (1993) 1.26
Deficiency in matrix metalloproteinase gelatinase B (MMP-9) protects against retinal ganglion cell death after optic nerve ligation. J Biol Chem (2002) 1.24
Axotomy-induced retinal ganglion cell death in adult mice: quantitative and topographic time course analyses. Exp Eye Res (2011) 1.20
SPARC-null mice exhibit lower intraocular pressures. Invest Ophthalmol Vis Sci (2009) 1.18
Expression of matrix metalloproteinases and inhibitor by human trabecular meshwork. Invest Ophthalmol Vis Sci (1991) 1.18
Ocular hypertension in mice with a targeted type I collagen mutation. Invest Ophthalmol Vis Sci (2003) 1.13
Genetic dependence of central corneal thickness among inbred strains of mice. Invest Ophthalmol Vis Sci (2009) 1.12
Effect of latanoprost on the expression of matrix metalloproteinases and their tissue inhibitors in human trabecular meshwork cells. Invest Ophthalmol Vis Sci (2006) 1.12
Synergism of TNF and IL-1 in the induction of matrix metalloproteinase-3 in trabecular meshwork. Invest Ophthalmol Vis Sci (2007) 1.11
Matrix metalloproteinase-2 and -9 as promising benefactors in development, plasticity and repair of the nervous system. Prog Neurobiol (2013) 1.11
Treatment of sheep steroid-induced ocular hypertension with a glucocorticoid-inducible MMP1 gene therapy virus. Invest Ophthalmol Vis Sci (2010) 1.11
Basement membrane-dependent survival of retinal ganglion cells. Invest Ophthalmol Vis Sci (2005) 1.10
Immunomicroscopical study of type VI collagen in the trabecular meshwork of normal and glaucomatous eyes. Exp Eye Res (1989) 1.10
Severity of optic nerve damage in eyes with POAG is correlated with changes in the trabecular meshwork. J Glaucoma (1997) 1.06
Studies of scleral biomechanical behavior related to susceptibility for retinal ganglion cell loss in experimental mouse glaucoma. Invest Ophthalmol Vis Sci (2013) 1.04
The effect of mechanical strain on matrix metalloproteinase production by bovine trabecular meshwork cells. Curr Eye Res (2001) 0.99
Development of a gene therapy virus with a glucocorticoid-inducible MMP1 for the treatment of steroid glaucoma. Invest Ophthalmol Vis Sci (2010) 0.99
MMPs in the trabecular meshwork: promising targets for future glaucoma therapies? Invest Ophthalmol Vis Sci (2013) 0.98
Outflow facility in mice with a targeted type I collagen mutation. Invest Ophthalmol Vis Sci (2009) 0.98
Optic nerve damage in mice with a targeted type I collagen mutation. Invest Ophthalmol Vis Sci (2004) 0.97
Expression of matrix metalloproteinases and their inhibitors in human trabecular meshwork cells. Invest Ophthalmol Vis Sci (2003) 0.97
The Juxtacanalicular Region of Ocular Trabecular Meshwork: A Tissue with a Unique Extracellular Matrix and Specialized Function. J Ocul Biol (2013) 0.96
Soluble guanylate cyclase α1-deficient mice: a novel murine model for primary open angle glaucoma. PLoS One (2013) 0.96
Overexpression of SPARC in human trabecular meshwork increases intraocular pressure and alters extracellular matrix. Invest Ophthalmol Vis Sci (2013) 0.95
Thrombospondin-1 (TSP1)-null and TSP2-null mice exhibit lower intraocular pressures. Invest Ophthalmol Vis Sci (2012) 0.93
β1 integrin-focal adhesion kinase (FAK) signaling modulates retinal ganglion cell (RGC) survival. PLoS One (2012) 0.88
TIMP1, TIMP2, and TIMP4 are increased in aqueous humor from primary open angle glaucoma patients. Mol Vis (2015) 0.87
Tissue inhibitor of metalloproteinase 4 in aqueous humor of patients with primary open angle glaucoma, pseudoexfoliation syndrome and pseudoexfoliative glaucoma and its role in proteolysis imbalance. BMC Ophthalmol (2013) 0.87
Cyp1b1 mediates periostin regulation of trabecular meshwork development by suppression of oxidative stress. Mol Cell Biol (2013) 0.86
Noninvasive assessment of aqueous humor turnover in the mouse eye. Invest Ophthalmol Vis Sci (2003) 0.83
Hyaluronic acid increases MMP-2 and MMP-9 expressions in cultured trabecular meshwork cells from patients with primary open-angle glaucoma. Mol Vis (2012) 0.80
Altered expression of transforming growth factor beta 1 and matrix metalloproteinase-9 results in elevated intraocular pressure in mice. Mol Vis (2013) 0.79
A generic method for design of oligomer-specific antibodies. PLoS One (2014) 0.79
Ultrastructural abnormalities of the trabecular meshwork extracellular matrix in Cyp1b1-deficient mice. Vet Pathol (2014) 0.76
A freely available semi-automated method for quantifying retinal ganglion cells in entire retinal flatmounts. Exp Eye Res (2016) 0.76
Towards axonal regeneration and neuroprotection in glaucoma: Rho kinase inhibitors as promising therapeutics. Prog Neurobiol (2015) 0.93
Matrix Metalloproteinases During Axonal Regeneration, a Multifactorial Role from Start to Finish. Mol Neurobiol (2016) 0.84
A proteomic approach to understand MMP-3-driven developmental processes in the postnatal cerebellum: Chaperonin CCT6A and MAP kinase as contributing factors. Dev Neurobiol (2015) 0.78
Differential visual system organization and susceptibility to experimental models of optic neuropathies in three commonly used mouse strains. Exp Eye Res (2016) 0.77
Neuroinflammation as Fuel for Axonal Regeneration in the Injured Vertebrate Central Nervous System. Mediators Inflamm (2017) 0.75
Successful optic nerve regeneration in the senescent zebrafish despite age-related decline of cell intrinsic and extrinsic response processes. Neurobiol Aging (2017) 0.75